{"id":539295,"date":"2021-09-16T16:04:19","date_gmt":"2021-09-16T20:04:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/"},"modified":"2021-09-16T16:04:19","modified_gmt":"2021-09-16T20:04:19","slug":"atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/","title":{"rendered":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Sept.  16, 2021  (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, which is being held from September 20 \u2013 23, 2021.<\/p>\n<p align=\"justify\">The presentation will take place on Wednesday, September 22, 2021, at 3:45 p.m. ET.<\/p>\n<p align=\"justify\">In addition to the presentation, management will be available to participate in virtual one-on-one meetings with investors who are registered attendees of the conference.<\/p>\n<p align=\"justify\">Following the event, a replay of the live presentations will be available on the Investor\u2019s section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UvONQolF3u4iUbgELptsuMh1jnTrzQ7EpmpggUCGTd92-Qp1y7YJZ3xIaCDKKYOkAgoSXUbDIA5rm6oLiYT2ZeNxwi3VneI1rbCgCxa2l98=\" rel=\"nofollow noopener\" target=\"_blank\">www.atyrpharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Abo<\/strong><br \/>\n        <strong>ut aTyr<\/strong>\n      <\/p>\n<p align=\"justify\">aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr\u2019s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr\u2019s primary focus is ATYR1923, a clinical-stage product candidate which binds to the Neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wvTUtVhWWfRY335Q8xD_U1Omb2TSXObZxdS_dBk6neCLGj1pqDbi3YCVJijIFD_kX1L5VOJxSXFmYZxIjvKUbw_n9EN96JAJ0Le6XCLKtMc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>http:\/\/www.atyrpharma.com<\/u><\/a>.<\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Contact:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Ashlee Dunston<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Director, Investor Relations and Corporate Communications<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:adunston@atyrpharma.com\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <u>adunston@atyrpharma.com<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2Q2MDEwYmYtN2FiOS00YThmLThiMWQtNTZlZmU0MjQ5NWY2LTEwMjkxNDI=\/tiny\/aTyr-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, which is being held from September 20 \u2013 23, 2021. The presentation will take place on Wednesday, September 22, 2021, at 3:45 p.m. ET. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with investors who are registered attendees of the conference. Following the event, a replay of the live presentations will be available on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-539295","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, which is being held from September 20 \u2013 23, 2021. The presentation will take place on Wednesday, September 22, 2021, at 3:45 p.m. ET. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with investors who are registered attendees of the conference. Following the event, a replay of the live presentations will be available on &hellip; Continue reading &quot;aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-16T20:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit\",\"datePublished\":\"2021-09-16T20:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/\",\"name\":\"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\",\"datePublished\":\"2021-09-16T20:04:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/","og_locale":"en_US","og_type":"article","og_title":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk","og_description":"SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, which is being held from September 20 \u2013 23, 2021. The presentation will take place on Wednesday, September 22, 2021, at 3:45 p.m. ET. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with investors who are registered attendees of the conference. Following the event, a replay of the live presentations will be available on &hellip; Continue reading \"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-16T20:04:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit","datePublished":"2021-09-16T20:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/","name":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=","datePublished":"2021-09-16T20:04:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzUxMyM0NDA5ODYwIzIwMTc1Njk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=539295"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539295\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=539295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=539295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=539295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}